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UK-prescriptions in terms of diagnostic tests, 86.0% [84.6–87.2]
in terms of consultations and referrals of GP and rheumatolo-
gists, and 64.7% [61.7–67.7] in terms of medications. NSAID,
SSRI antidepressants, tricyclic antidepressants and glucocorti-
coids are prescribed in respectively 15%, 11%, 12% and 2% of
the French patients. Patients are monitored by a GP for an
average of 17 visits per patient per year. On an average annual
basis, 13% of the patients are referred to a rheumatologist, 6%
to a psychiatrist, 13% to a radiologist, 56% to a medical biolo-
gist, 6% to an orthopaedist, and 1% to a geriatrician. On
average, 2.2 diagnostic tests per patient per year are prescribed.
CONCLUSIONS: The French expert panel fairly agreed with the
medical resources prescribed by GP in UK; agreement rates
ranged between 65% and 86%. These results conﬁrm the diver-
sity in treatments and the multidisciplinary management of
patients suffering from ﬁbromyalgia.
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OBJECTIVES: Women with osteoporosis do not follow their
treatment strictly and it is necessary to assess, describe and
explain why. A literature review did not allow speciﬁc osteoporo-
sis questionnaires assessing adherence (i.e. signiﬁcant and self-
conscious involvement of patients in their treatment) to be
identiﬁed. The objective was thus to develop a tool to evaluate
adherence to treatment of women with osteoporosis.
METHODS: Face-to-face semi-directive interviews were con-
ducted with 10 women with osteoporosis. Interpretative Phe-
nomenological Analysis (IPA) was undertaken using the full
transcripts of interviews. The numerous concepts identiﬁed with
IPA were discussed with experts and relevant concepts for adher-
ence were organised into a conceptual model. Items were then
generated for each detailed concept using patients’ own words.
The questionnaire was then tested for relevance and comprehen-
sion with 5 other women with osteoporosis, and revised accord-
ingly. RESULTS: The conceptual model included various
elements linked to adherence to treatment: personal data, beliefs,
perceptions, behaviour and information received. Several items
were generated for each general concept and organised into
sections about osteoporosis, treatment, information received
about osteoporosis and treatment, and osteodensitometry test.
Except a few items that were modiﬁed or deleted, the majority of
the items were well understood, and considered relevant and
adequate by patients during comprehension tests. The revised
questionnaire contained 44 items. CONCLUSIONS: This ques-
tionnaire is a unique and promising tool that provides a compre-
hensive and speciﬁc evaluation of women’s adherence to
osteoporosis treatment. A future pilot study with 10 clinicians
and 30 women with osteoporosis is planned in real conditions of
use to assess if the questionnaire is well accepted by both clini-
cians and patients in clinical practice. A validation study will
then be undertaken to validate psychometric properties and
scoring of the questionnaire, and to demonstrate that the score is
predictive of patients’ actual behaviour.
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OBJECTIVES:Description of HUI3 and EQ-5D utility values and
their relationwithHAQscore.METHODS:Observational, cross-
sectional, naturalistic and multicentre study. A total of 244
patients aged 18 or more and with rheumatoid arthritis (RA)
according to ACR diagnosis criteria were recruited by 14 Spanish
rheumatologists over a 2-month period. Social (age, gender and
race) and clinical variables (time of disease evolution, current
affected joints and RA family history) were collected. Patients
were also asked to fulﬁl three generic HRQoL questionnaires:
Health Assessment Questionnaire (HAQ), Health Utility Index
(HUI) and Euroqol (EQ-5D). Two linear regression models were
used to predict HUI3 and EQ-5D utility values as functions of
HAQ scores and age and gender. RESULTS: Mean age (SD) of
patients was 57.8 (13.3) years, being 75.8% women and 96%
Caucasians. Mean time of disease evolution (SD) was 10.8 (9)
years. Patients’ distribution according to HAQ severity level
groups was: 29% in level 1 (<0.5), 28% in level 2 (0.5 < HAQ
> 1.1), 16% in level 3 (1.1 < HAQ < 1.6), 15% in level 4 (1.6 <
HAQ < 2.1) and 12% in level 5 (>2.1). HAQ and EQ-5D mean
scores (SD) were 1.02 (0.78) and 63.1 (20.3), respectively. Mean
utility values (SD) for HUI and TTO (Time-trade-off) were 0.75
(0.21) and 0.65 (0.3), respectively. The functions convertingHAQ
scores into utilities are HUI3 = 0.9527 - (0.2018 ¥ HAQ) + e
(R2 = 0.560, e = 0 (0.14)) and TTO = 0.9567 - (0.309 ¥ HAQ) +
e (R20.54, e = 0 (0.22). Non-normal error distribution was found.
Age and gender showed no inﬂuence on this relation and only
HAQ score was ﬁnally included in the functions. CONCLU-
SIONS: The relation between HUI3 and EQ-5D utility values and
HAQ score has been proved. By obtainingHAQ score it is possible
to calculate the utility values for the other two questionnaires.
However, the resulting functions are not too robust and should be
used having into consideration their limitations.
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OBJECTIVES: The goal of this study was to evaluate the rela-
tionship amongst patient expectations and outcomes measured
by health related quality of life (HRQOL) questionnaires at 12
months after surgery in patient undergoing total joint replace-
ment. METHODS: In this prospective study took part 15 hospi-
tals. The questionnaire was sent to the patients while waiting for
total hip (THR) or knee replacement (TKR) and 12 months
post-surgery. In this questionnaire were included speciﬁc
HRQOL instrument WOMAC, two generic instruments SF-12
and EQ-5D and eight questions about patient’s expectations
which were grouped into physic-functional (5), emotional (2)
and psychological expectations (1). The responses of the expec-
tation questions were graded on a 5 point Likert scale ranging
from “no expectations” to “a lot of expectations”. Given the
skewed distribution of the response patterns these were catego-
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